These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry. Koga M; Gilbert M; Li J; Koike S; Takahashi M; Furukawa K; Hirata K; Yuki N Neurology; 2005 May; 64(9):1605-11. PubMed ID: 15883324 [TBL] [Abstract][Full Text] [Related]
3. Campylobacter coli enteritis and Guillain-Barré syndrome: no evidence of molecular mimicry and serological relationship. Funakoshi K; Koga M; Takahashi M; Hirata K; Yuki N J Neurol Sci; 2006 Jul; 246(1-2):163-8. PubMed ID: 16600306 [TBL] [Abstract][Full Text] [Related]
4. Anti-ganglioside antibody and neuropathy: review of our research. Yuki N J Peripher Nerv Syst; 1998; 3(1):3-18. PubMed ID: 10959233 [TBL] [Abstract][Full Text] [Related]
5. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan. Ogawara K; Kuwabara S; Mori M; Hattori T; Koga M; Yuki N Ann Neurol; 2000 Oct; 48(4):624-31. PubMed ID: 11026446 [TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of Guillain-Barré and Miller Fisher syndromes subsequent to Campylobacter jejuni enteritis. Yuki N Jpn J Infect Dis; 1999 Jun; 52(3):99-105. PubMed ID: 10507987 [TBL] [Abstract][Full Text] [Related]
7. Lipopolysaccharides in the development of the Guillain-Barré syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies. Prendergast MM; Moran AP J Endotoxin Res; 2000; 6(5):341-59. PubMed ID: 11521055 [TBL] [Abstract][Full Text] [Related]
12. Ganglioside mimicry as a cause of Guillain-Barré syndrome. Komagamine T; Yuki N CNS Neurol Disord Drug Targets; 2006 Aug; 5(4):391-400. PubMed ID: 16918391 [TBL] [Abstract][Full Text] [Related]
13. [Anti-GQ1b IgG-negative case of overlapping Fisher's and Gullain-Barré syndromes after Campylobacter jejuni (PEN 19) enteritis]. Hayashi Y; Koga M; Takahashi M; Uchida A; Yuki N Rinsho Shinkeigaku; 2001 Nov; 41(11):801-4. PubMed ID: 12080613 [TBL] [Abstract][Full Text] [Related]
14. Recognition characteristics of monoclonal antibodies that are cross-reactive with gangliosides and lipooligosaccharide from Campylobacter jejuni strains associated with Guillain-Barré and Fisher syndromes. Houliston RS; Yuki N; Hirama T; Khieu NH; Brisson JR; Gilbert M; Jarrell HC Biochemistry; 2007 Jan; 46(1):36-44. PubMed ID: 17198373 [TBL] [Abstract][Full Text] [Related]
15. [Antiganglioside antibodies: when, which and for what]. Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721 [TBL] [Abstract][Full Text] [Related]
16. Preceding infections and anti-ganglioside antibodies in patients with Guillain-Barré syndrome: a single centre prospective case-control study. Sinha S; Prasad KN; Jain D; Pandey CM; Jha S; Pradhan S Clin Microbiol Infect; 2007 Mar; 13(3):334-7. PubMed ID: 17391394 [TBL] [Abstract][Full Text] [Related]
17. Antibodies to gangliosides and ganglioside complexes in Guillain-Barré syndrome and Fisher syndrome: mini-review. Kaida K; Kusunoki S J Neuroimmunol; 2010 Jun; 223(1-2):5-12. PubMed ID: 20172612 [TBL] [Abstract][Full Text] [Related]
18. Antiganglioside antibodies in Guillain-Barré syndrome and its related conditions. Shahrizaila N; Yuki N Expert Rev Neurother; 2011 Sep; 11(9):1305-13. PubMed ID: 21864076 [TBL] [Abstract][Full Text] [Related]
19. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome. Koga M; Takahashi M; Masuda M; Hirata K; Yuki N Neurology; 2005 Nov; 65(9):1376-81. PubMed ID: 16162859 [TBL] [Abstract][Full Text] [Related]
20. Relationship of bacterial strains to clinical syndromes of Campylobacter-associated neuropathies. Kimoto K; Koga M; Odaka M; Hirata K; Takahashi M; Li J; Gilbert M; Yuki N Neurology; 2006 Nov; 67(10):1837-43. PubMed ID: 17130419 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]